On Friday, August 22nd, the U. S. Drug Enforcement Administration (DEA) published a Final Rule moving hydrocodone combination products (HCPs) from Schedule III to the more-restrictive Schedule II. This Final Rule imposes the regulatory controls and sanctions applicable to Schedule II substances on those who handle or propose to handle HCPs. The rule goes into effect 45 days from its publish date.
More Latest News
January 2, 2020
Click here for the new requirements requiring prescribers to generate and transmit all prescriptions electronically Continue reading
December 16, 2019
The Quarterly Performance Report for the first quarter of the 2019-2020 fiscal year is now available online. Continue reading